Notice :
Impact of Recent Change Health Care National Outage. Learn More

Trial Protocol ID
USOR 21270_ZN-c3-005 *RIT*

Investigator
Syed Shahid Mahmood, M.D.

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Trial Protocol ID
USOR 21271_ZN-c3-004 | GOG 3065_TITAN

Investigator
Jeanine L Werner, M.D.

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma (ZN-c3-004 | GOG 3065) (TITAN)